FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
GlobalData on MSN6d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
Keeping MS under control: New treatments finally bring hope to Floridians living with multiple sclerosis
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...
BioSpace6d
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
FiercePharma6d
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
News Medical on MSN5d
New drug candidate shows potential to restore vision in people with MS
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
The American Journal of Managed Care7d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
devdiscourse4d
Breakthrough Drug Offers New Hope for Restoring Vision in MS Patients
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
Medscape8d
FDA Adds Anaphylaxis Risk Warning to Multiple Sclerosis Drug Glatiramer Acetate
From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...
MedPage Today7d
FDA Warns About Anaphylaxis Risk With MS Drug
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
U.S. health regulator warns of serious allergic reactions with multiple sclerosis drugs
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
Reuters8d
FDA warns of serious allergic reactions with some multiple sclerosis drugs
Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...